Schonfeld Strategic Advisors’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,974
| Closed | -$48.1K | – | 1845 |
|
|
2023
Q2 | $48.1K | Buy |
+8,974
| New | +$48.1K | ﹤0.01% | 1707 |
|
|
2023
Q1 | – | Sell |
-15,498
| Closed | -$290K | – | 2246 |
|
|
2022
Q4 | $290K | Sell |
15,498
-8,129
| -34% | -$152K | ﹤0.01% | 1792 |
|
|
2022
Q3 | $489K | Buy |
23,627
+13,385
| +131% | +$277K | ﹤0.01% | 1738 |
|
|
2022
Q2 | $213K | Buy |
10,242
+9,325
| +1,017% | +$194K | ﹤0.01% | 1777 |
|
|
2022
Q1 | $40K | Sell |
917
-2,208
| -71% | -$96.3K | ﹤0.01% | 2294 |
|
|
2021
Q4 | $187K | Buy |
3,125
+1,225
| +64% | +$73.3K | ﹤0.01% | 1698 |
|
|
2021
Q3 | $163K | Sell |
1,900
-2,713
| -59% | -$233K | ﹤0.01% | 1743 |
|
|
2021
Q2 | $513K | Buy |
+4,613
| New | +$513K | 0.01% | 1139 |
|
|
2021
Q1 | – | Sell |
-8,870
| Closed | -$942K | – | 1893 |
|
|
2020
Q4 | $942K | Buy |
8,870
+8,025
| +950% | +$852K | 0.01% | 798 |
|
|
2020
Q3 | $118K | Buy |
+845
| New | +$118K | ﹤0.01% | 1218 |
|